Retaglutide and tirzepatide are groundbreaking GLP-1 receptor agonists gaining recognition as effective treatment options for type 2 diabetes. These medications promote insulin secretion from the pancreas, reduce https://liviatuuz268331.aboutyoublog.com/48257774/novel-agents-in-diabetes-management